19:40 , Oct 3, 2017 |  BC Innovations  |  Distillery Therapeutics

Autoimmune disease

INDICATION: Multiple sclerosis (MS) Patient sample and mouse studies suggest inhibiting MIF and DDT or their receptor CD74 could help treat progressive MS. In patients and healthy volunteers, genotyping identified associations between two polymorphisms in...
07:00 , Sep 21, 2009 |  BC Week In Review  |  Clinical News

RTL1000: Phase I data

A double-blind, placebo-controlled, U.S. Phase I trial in 34 patients with relapsing, remitting and secondary multiple sclerosis established an undisclosed MTD for IV RTL1000. The company said the product was biologically active in a subgroup...
07:00 , Jun 28, 2004 |  BC Extra  |  Financial News

Virogenomics spins out Artielle

Virogenomics (Portland, Ore.) spun out its autoimmune disease technology into Artielle ImmunoTherapeutics . The technology, licensed from Oregon Health & Science University (Portland, Ore.), is based on using recombinant T cell receptor ligands. Virogenomics in-licenses...